4i is the first imaging technique which gives a view of biological samples and links multiplexed information in one and the same experiment.
(UZH/Science)
Researchers at the University of Zurich (UZH) have developed a novel method to visualise proteins and generate a comprehensive map of cellular organisation, which could help improve cancer diagnosis and therapy selection.
The method, dubbed 4i for iterative immunofluorescence imaging, is an improvement over standard imaging techniques used in biomedicine because it can generate a systematic survey of the cellular landscape, increasing more than tenfold the number of proteins visible per sample.
According to a UZH statementexternal link, 4i makes it possible to see the distribution of at least 40 proteins in thousands of cells at the same time, and across various levels, from the tissue down to subcellular structures.
“Imagine cell biologists to be journalists. Every experiment is an interview with our cells. With conventional immunofluorescence I can ask three questions, whereas with 4i I can have a discussion on more than 40 topics,” explained Gabriele Gut, a researcher at UZH’s Institute of Molecular Life Sciences and lead author of a paper published this week in the journal Scienceexternal link.
The researchers hope the new method will advance precision medicine, notably in cancer diagnosis.
“We hope that 4i and multiplexed protein maps will help researchers to understand processes better that have been at the centre of biological research for decades,” she added.
The new method can also be used to determine the effects of pharmacological substances on the organisation and physiology of cells.
All rights reserved. The content of the website by swissinfo.ch is copyrighted. It is intended for private use only. Any other use of the website content beyond the use stipulated above, particularly the distribution, modification, transmission, storage and copying requires prior written consent of swissinfo.ch. Should you be interested in any such use of the website content, please contact us via contact@swissinfo.ch.
As regards the use for private purposes, it is only permitted to use a hyperlink to specific content, and to place it on your own website or a website of third parties. The swissinfo.ch website content may only be embedded in an ad-free environment without any modifications. Specifically applying to all software, folders, data and their content provided for download by the swissinfo.ch website, a basic, non-exclusive and non-transferable license is granted that is restricted to the one-time downloading and saving of said data on private devices. All other rights remain the property of swissinfo.ch. In particular, any sale or commercial use of these data is prohibited.
